Skip to Content
Browse all medications
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Advanced Search
Phonetic Search
Search:
Drugs A-Z
Pill Identifier
Interactions Checker
News
Health Professionals
Q & A
Mednotes
Apps
Home
→
News
→
Clinical Trials
→
Merck presents...
Print
Save or Share
Merck presents data on its investigational Cat K Inhibitor, odanacatib
Posted: October 2010
View comments
More News Resources
FDA Medwatch Drug Alerts
FDA Drug Safety Labeling Changes
Daily MedNews
Pharma Industry News
New Drug Approvals
New Drug Applications
Clinical Trial Results
Generic Drug Approvals
Monthly Update Archive
Search:
Sign In
or
Register
Recently Approved
Mekinist
Mekinist (trametinib) is a kinase inhibitor indicated for the treatment of patients with unresectable or...
Tafinlar
Tafinlar (dabrafenib) is a kinase inhibitor indicated for the treatment of patients with unresectable or...
Xofigo
Xofigo (radium 223 dichloride) is an alpha particle-emitting radioactive therapeutic agent indicated for...
Nymalize
Nymalize (nimodipine) is a calcium channel blocker indicated to improve neurological outcome following...
Breo Ellipta
Breo Ellipta (fluticasone and vilanterol) is a once-a-day inhaled corticosteroid / long-acting beta2 agonist...
More...
Get Updates by Email
Email me:
FDA Medwatch Alerts
News Roundup
Daily
Weekly
Monthly
Email
Advertisement
Close
Recommended
Symptom Checker
(web2)